.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Adult Immune Thrombocytopenia Purpura

EP. 1: ITP Pathogenesis, Presentation, and Diagnostic Workup

January 24th 2019

EP. 2: ITP Treatment Selection Criteria and Treatment Goals

January 24th 2019

EP. 3: ITP Patient Management and Important Treatment Factors

January 24th 2019

EP. 4: First-Line Therapy Options for Patients with ITP

January 24th 2019

EP. 5: Steroid Combination Therapy & New ASH Guidelines

January 24th 2019

EP. 6: Second-Line Treatment Options for Patients with ITP

January 24th 2019

EP. 7: Fostamatinib as Second-Line ITP Therapy

January 24th 2019

EP. 8: Romiplostim Classification and Mechanism of Action

January 24th 2019

EP. 9: TPO Receptor Agonist Selection and Patient Adherence

January 24th 2019

EP. 10: TPO Duration of Response and Toxicity

January 24th 2019

EP. 11: Rituximab and Salvage Therapies for Patients With ITP

January 24th 2019

EP. 12: The Future of ITP Treatment

January 24th 2019